Pay in 4 interest-free payments of $30.00 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
D-erythro-MAPP (D-e-MAPP) reduces the viability of MCF-7 cells in a dose-dependent manner with IC50 value of 4
Yoshizawa S
2 μM for K2P2
ATPγS results in a dose-dependent effect on EBA extravasation in LPS-treated mice
BMS-309403 Catalog No.:M20293-C D-erythro-MAPP (D-e-MAPP) reduces the viabilityBMS 309403 is a potent, orally active and selective adipocyte fatty acid binding protein (also known as FABP4, aP2) inhibitor with Kis of <2, 250, and 350 nM for FABP4, FABP3, and FABP5, respectively. BMS 309403 interacts with the fatty acid binding pocket within the interior of the protein and competitively inhibits the binding of endogenous fatty acids. BMS 309403 improves endothelial function in apolipoprotein E deficient mice and in cultured human